Industry Analysis Medical & Healthcare

Acne Drugs Market to Surge at 12.76% CAGR, which is anticipated to reach USD 6.89 billion by 2030

CRI Report has released a report titled “Acne Drugs Market–Global Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030” which is anticipated to reach USD 6.89 billion by 2030. According to a study by CRI Report, the market is anticipated to portray a CAGR of 12.76% between 2020 and 2030. According to the report, a rise in the manifestation of acne among teenagers and mounting consciousness of acne treatments are the prime factors to drive the Acne Drugs Market growth. An increase in disposable income and skin problems due to unhealthy lifestyles and sun and pollution exposure is set to boost the demand for Acne Medications throughout the forecast period. Disposable income, rising pollution levels, and an increasing number of skin orders are some factors primarily bound to grow the Acne Drugs Market growth. Unhygienic eating habits, regular changing lifestyles, and cosmetics among young teens have prompted the Global market. However, advancement in technologies is booming the Global Acne Drugs Market.

The market report on Acne Drugs Market includes in-depth insights as:

  • The estimated value of the market was USD 6.89 billion in the year 2020.
  • Acne Drugs in North America held the largest market share in the year 2020.
  • Based on Applications, E-pharmacies and Retail emerged as a key segment in the Acne Drugs market.
  • Based on Drug Type, Antibiotics and Topical Retinoid emerged as a key segment in the Acne Drugs market.
  • Key players are likely to focus on product innovations and expansion through mergers to retain their positions in developed markets.

“Escalation in the disposable income of the consumers is expected to boost the demand for the Acne Drugs. Acne medications are generally used for moderate to severe acne cases. Mounting concerns for consumer’s own physical appearances is set to develop the Acne Drugs Market growth. Owing to changing lifestyles and high prevalence among teens have tended to drive the Acne Drugs Market growth. Consumer’s shift in the eating customs and the increasing air pollution is causing the rate of acne which is predictable to certainly impact the market growth”

Acne drugs are the treatments that are directly applied to the exposed or affected skin such as, benzoyl peroxide, azelaic acid, and salicylic acid, are some of the commonly used acne treatments. Acnes are serious skin diseases leading to prominent psychological and emotional issues. They are treated by dermatologists and other healthcare providers. Generally, acne is a disorder of the pilosebaceous units produced by hormones. Hormone analogs are the medications that can most frequently activate acne medicamentosa. Folliculitis is the most common mimic medicamentosa generated by the overgrowth of the Malassezia species, often secondary to broad-spectrum antibiotics such as the tetracycline family used in acne.

Acne Drug Market is segmented by Drug type into Antibiotics, Anti-Microbial, Hormonal Agents, Retinoid and Others. The retinoid segment is anticipated to dominate the Acne Drug Market. Retinoid is a retinoic or a Vitamin A acid that has anti-inflammatory properties. Retinoids are the most effective drugs for moderate to severe acne as they unblock the pores and let the acne gels work efficiently over the skin. The Retinoid segment is boosting the production of new skin cells and is projected to be the fastest-growing segment in Acne Drugs Market. Furthermore, the Antibiotics segment has also witnessed the prompting growth due to its high efficiency in exudate management of acne.

Key Players in the Market

  • Some of the key players operating in the Acne Drugs Market Sun Pharmaceuticals Industries Limited, Johnson & Johnson, Almirall SA., Teva Pharmaceuticals Industries Limited, Valeant Pharmaceuticals Industries Limited., Glaxo SmithKline Plc, Mylan N.V., Mayne Pharma Group Limited, Nestle SA, Bausch Health Companies Inc.

Get Valuable Insights into Acne Drugs Market

In the new report, CRI Report thrives to present an unbiased analysis of the Acne Drugs Market that covers the historical demand data as well as the forecast figures for the period, i.e., 2021-2030. The study includes compelling insights into growth that is witnessed in the market. Acne Drugs market is segmented by Acne Type into Inflammatory, Non-Inflammatory, Comedonal, Post-Surgical and Others; by Applications into Hospital, Online, E-pharmacies, Retail, and Others; by Drug Type into Antibiotics, Anti-Microbial, Hormonal Agents, Topical Retinoid and Others. Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East, and Africa.

    Request a sample

    Related posts

    Follow by Email